Home › Funds › MPM BioImpact LLC › ALMS
MPM BioImpact LLC position in ALMS
ALUMIS INC · Health Care
MPM BioImpact LLC reported holding 2,019,020 shares of ALMS (ALUMIS INC) in its Q2 2026 13F filing — a position valued at US$56.8M, representing 3.46% of its reported portfolio and ranking #10 among its reported holdings. MPM BioImpact LLC has disclosed ALMS holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How MPM BioImpact LLC's ALMS position evolved
MPM BioImpact LLC first disclosed a stake in ALMS in Q4 2025 at 2,401,992 shares (US$23.4M). The position peaked in Q2 2026 at 2,019,020 shares, worth US$56.8M. Across 3 filings, MPM BioImpact LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 2,019,020 shares valued at US$56.8M — a reduction of -367,509 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 2.40M | $23.44M | New |
| Q1 2026 | 2.39M | $52.58M | Reduce |
| Q2 2026 | 2.02M | $56.82M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALMS and 13F data
ALMS (ALUMIS INC) is a Health Care company. 88 other funds we track also report a position in ALMS — the largest reported positions include AyurMaya Capital Management Company, LP (US$426.0M), Deep Track Capital, LP (US$178.6M), Samsara BioCapital, LLC (US$178.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALMS
- AyurMaya Capital Management Company, LP 15.14M sh · $426.03M · Q2 2026
- Deep Track Capital, LP 6.35M sh · $178.65M · Q2 2026
- Samsara BioCapital, LLC 6.35M sh · $178.55M · Q2 2026
- Foresite Capital Management V, LLC 5.90M sh · $165.94M · Q2 2026
- venBio Partners LLC 4.53M sh · $127.43M · Q2 2026
- Foresite Capital Management VI LLC 4.25M sh · $119.53M · Q2 2026
- Nextech Invest Ltd. 3.54M sh · $99.64M · Q2 2026
- Cormorant Asset Management, LP 3.29M sh · $92.46M · Q2 2026
- Saturn V Capital Management LP 2.92M sh · $82.04M · Q2 2026
- Octagon Capital Advisors LP 2.83M sh · $79.66M · Q2 2026
- BAKER BROS. ADVISORS LP 2.01M sh · $56.63M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 1.96M sh · $55.15M · Q2 2026
More on MPM BioImpact LLC
FAQ
How long has MPM BioImpact LLC held ALMS?
MPM BioImpact LLC has disclosed ALMS holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is MPM BioImpact LLC's current position in ALMS?
As of Q2 2026, MPM BioImpact LLC holds 2.02M shares of ALMS (ALUMIS INC), valued at $56.82M, representing 3.46% of its reported portfolio and ranking #10.
Has MPM BioImpact LLC been buying or selling ALMS?
In the latest 13F filing (Q2 2026), MPM BioImpact LLC reduced its position in ALMS. The position peaked in Q2 2026 at 2.02M shares.
Which other funds hold ALMS?
Other major institutional holders of ALMS include AyurMaya Capital Management Company, LP, Deep Track Capital, LP, Samsara BioCapital, LLC, among 88 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.